Insulin Analog [EPC]

272411 reported adverse events

Drugs of this class: INSULIN LISPRO INSULIN ASPART INSULIN GLARGINE INSULIN DETEMIR (INSULIN DEGLUDEC AND LIRAGLUTIDE) INSULIN ASPART INJECTION INSULIN DEGLUDEC INSULIN DEGLUDEC INJECTION INSULIN GLARGINE AND LIXISENATIDE INSULIN GLULISINE INSULIN LISPRO-AABC WATER INJECTION

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 56808
1 BLOOD GLUCOSE DECREASED 14432
2 DRUG INEFFECTIVE 13205
3 NAUSEA 11426
4 HYPOGLYCAEMIA 9267
5 MALAISE 8457
6 INCORRECT DOSE ADMINISTERED 8316
7 VISUAL IMPAIRMENT 7952
8 FATIGUE 7570
9 DYSPNOEA 7457
See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE OPERATIONAL ISSUE 1757 0.8816
1 HYPOGLYCAEMIC UNCONSCIOUSNESS 1113 0.6661
2 HYPOGLYCAEMIA UNAWARENESS 206 0.6561
3 ANTI-INSULIN ANTIBODY POSITIVE 118 0.6178
4 INTERCEPTED PRODUCT SELECTION ERROR 260 0.5317
5 HYPOGLYCAEMIC SEIZURE 391 0.5277
6 BLOOD KETONE BODY 131 0.4925
7 DIABETIC HYPERGLYCAEMIC COMA 116 0.4677
8 DIABETIC RETINOPATHY 1068 0.4625
9 SHOCK HYPOGLYCAEMIC 161 0.4237
See all enriched reactions for Insulin Analog [EPC]